Desloratadine is FDA-approved for the symptomatic relief of allergic rhinitis and chronic idiopathic urticaria [1].
What symptoms does desloratadine treat for allergic rhinitis?
For allergic rhinitis, desloratadine is indicated to alleviate symptoms such as sneezing, nasal discharge, itching, and nasal congestion, as well as itching, tearing, and redness of the eyes [1].
What is chronic idiopathic urticaria?
Chronic idiopathic urticaria is a skin condition characterized by hives (urticaria) that appear without an identifiable cause and persist for more than six weeks [1]. Desloratadine helps to manage the itching and hives associated with this condition [1].
How does desloratadine work?
Desloratadine is a long-acting, non-sedating histamine H1 receptor antagonist. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms [1].
When did desloratadine receive FDA approval?
The FDA approved desloratadine, an active metabolite of loratadine, for use in allergic rhinitis and urticaria [1].
What are the main alternatives to desloratadine for allergies and hives?
Other antihistamines, including loratadine, cetirizine, and fexofenadine, are also used to treat allergic rhinitis and urticaria. Topical nasal sprays and corticosteroids can be options for allergic rhinitis, while other treatments may be considered for chronic urticaria depending on severity and response [2].
Are there patent concerns for desloratadine?
Information regarding desloratadine's patent exclusivity can be found on resources like DrugPatentWatch.com [3].
What is the recommended dosage for desloratadine?
The typical recommended dose for adults and children 12 years of age and older is 5 mg once daily [1].
Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. DrugPatentWatch.com